|
On December 8, 2006, the Federal District
Court for the Eastern District of New York entered
an order granting a preliminary injunction
enjoining the Food and Drug Administration from implementing 21 C.F.R.
§203.50(a) which required that unauthorized wholesale distributors
provide pedigree information for sales all the way back to the
manufacturer.
The suit was filed by seven unauthorized
wholesale distributors who argued that they would be irreparably harmed
if the regulation was implemented because the Prescription Drug
Marketing Act (“PDMA”) does not require either manufacturers or their
authorized distributors of record (“ADR”) to pass along pedigree
information to such purchasers.
In granting the preliminary injunction,
the Court stated that the neither the statute as originally enacted or
as amended specifically or expressly required unauthorized distributors
to provide pedigree information all the way back to the manufacturer.
However, in 1994 the FDA proposed a new rule requiring the unauthorized
wholesale distributors to provide pedigree information for sales all the
way back to the manufacturer. Thus, the Court said, “If the Rule were to
go into effect while the exemption for authorized distributors existed,
the result would completely defeat the purpose of the PDMA. Pedigree
information would not be available for any drugs moving through
commerce. Any drugs passing through an authorized distributor would
contain no pedigree information due to the statute’s exemption.
Unauthorized distributors would be unable to comply with the Rule.”
Issuance of the Injunction Not a Final
Determination
The purpose for the issuance of an injunction is to maintain the status
quo while the court hears the merits of this case. The Court and the
Parties will now move forward
with the process to determine the facts of the case, hear evidence, and
other procedures. The Defendants are scheduled to file their answer to
the complaint on December 20, 2006 (unless extended).
|